Genentech v. Millennium Therapeutics (Super. Ct. CA 2027)(post-expiration patent royalty under process patent license)
Categories
Category: Expert Witness History
BSK D.O.O. (Serbia) v. Blueline Equip. (USA) (ICC Belgrade 2026)(reasonable royalty)
Categories
Susman Godfrey & K&L Gates
Biohaven Therapeutics & Yale Univ. v. Avilar Therapeutics (D. Del. 2025)
(rights and duties under confidential disclosure agreement regarding evaluation for possible Investment in life sciences matter)
Howmedica v. Howard (D.N.J. 2024)
(reasonableness of protection of trade secret matter)
BHI Energy v. KVP Holdings (N.D. Tx. 2023-24)
(addressing reasonableness of trade secrecy measures)
Categories
DLA Piper (D.C.)
Washington Pub. Co. v Open Text (JAMS D.C. 2022) (software licensing)
(considering royalty entitlements in sublicenses under a master software license agreement)
Categories
Clyde & Co. (Paris)
iXblue v. Safran (ICC N.Y. and Paris 2022) Addressing confidentiality practices in show-how transfer in a patent and trade secret field-of-use nonexclusive license
Categories
Daewoong Pharma (S. Korea)
In the matter of certain Botulinum Toxin Products (ITC Inv. 337-TA-1145 2021) Sponsored public interest submission to ITC criticizing ALJ’s ruling that claimant’s bacteria is a trade secret. ITC reversed ALJ ruling.
Categories
Harcus Parker (London)
Major Commodity Enterprise v. Media Company (High Court of Justice London 2020) (addressing interplay between trade secret owner’s property right and First Amendment rights of publisher in relation to a parallel action pending in the S.D.N.Y.)
Categories
Nobel Biocare
Bichacho et al v. Nobel Biocare Services AG (ICC Zurich 2018) (analysis of controlling principles for assessing U.S. patent damages in respect of independent and dependent claims)